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Transiliac Bone Biopsy
Complications and diagnostic value
Sudhaker D. Rao, MB, BS,* Velimir Matkovic, MD, PhD,** and Howard Duncan, MB, BS'

This article reviews the experience of 101 transiliac bone
biopsies performed in one year at Henry Ford Hospital and
discusses the possible diagnostic value ofthe procedure in
evaluating generalized metabolic bone disease. In 50 ofthe
101 cases, we used a pain scoring method to evaluate the
acceptability of the procedure to patients. Data from our
study and 18 other clinical centers were then analyzed for:
I) demographic distribution of patients who had a bone
biopsy; 2) its acceptability to patients; 3) quality of the
specimen and its relationship to the physician performing

the procedure; 4) diagnostic yield of bone biopsy; and 5)
complications of the procedure. Transiliac bone biopsy is
reasonably acceptable to patients and does not sacrifice the
quality of bone needed for diagnostic purposes. With improved instrumentation, it can be performed on outpatients
and does not require elaborate physical facilities. We conclude that transiliac bone biopsy should be performed on
all patients with metabolic bone disease unless the diagnosis is obvious.

H i s t o l o g i c examination of tissue biopsy specimens has
become an integral part of medicine. With improved instrumentation many procedures can now be performed in
outpatients and do not require elaborate physical facilities.
Transiliac bone biopsy is no exception (1,2). It provides an
adequate sample both for diagnosis and for micromorphometric and histodynamic study of bone in various
metabolic bone diseases. While bone biopsy has been a
routine procedure to identify local lesions for some decades, its use in evaluating generalized metabolic bone
disease has received little attention. Although transiliac
bone biopsy is considered a research tool by many physicians, this article describes its use as a diagnostic aid in the
field of bone and mineral metabolism. The detailed technique of performing a bone biopsy is discussed elsewhere
(3). Essentially it consists of removing a small core of
cortical and trabecular bone from the ilium approximately

3 cms posterior and 3 cms inferior to anterior superior iliac
spine, through a small skin and muscle incision (3).

Materials and Methods
Between January and December 1979, 101 transiliac bone
biopsies were performed by three physicians (A, B, and C)
at Henry Ford Hospital. Physician A learned the procedure
from physician C and taught it to physician B. In vivo,
double tetracycline labeling was used for all patients prior
to bone biopsy, so that measurements of histodynamic data
on the specimen could be made (4,5).
As a part of the study, data from 18 clinical centers where
bone biopsies are performed were pooled for analysis of
complications (6). Data were analyzed for: 1) demographic
distribution of patients who had a bone biopsy; 2) its
acceptability to patients (see pain score below); 3) quality
o f t h e specimen and its relationship to the physician performing the procedure; 4) diagnostic yield of bone biopsy;
and 5) complications o f t h e procedure.

* Bone and Mineral Research Laboratory Department of Internal Medicine, Henry Ford Hospital
** Formerly, Bone and Mineral Research Laboratory, Henry Ford Hospi-

To determine a pain score, we assessed patient discomfort
on a scale of 0 to 4: 0, no discomfort; 1, mild; 2, moderate;
3, severe; 4, excruciating or unbearable. Pain scoring was
done only for patients of physician A and was initiated
during the latter part ofthe study so that a total of only 50
consecutive patients were available for analysis. Scoring
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Zagreb, Yugoslavia
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TABLE II
Pain Score (Physician A Only)

was done once at the end ofthe procedure and again when
sutures were removed seven days later. Ancillary personnel
and the patient's own physicians helped in overall assessment of pain score.

Score
0
1
2
3
4

Results
There were 85 women and 16 men (Table I). As a group,
men were five years younger than women, but the mean
value was not significantly different. Black men were the
youngest of the group (<50 years of age), but in each
patient a secondary cause for accelerated bone loss was
present: two had renal osteodystrophy, one had total gastrectomy for Zollinger-Ellison syndrome, and one had insulin-dependent diabetes m e l l i t u s . The pattern of
distribution by age, sex, and race is similar to that for
osteoporotic patients in general.

Age (Years)
White
White
Black
Black

Women
Men
Women
Men

Total
Women
Men

(Mean ± SD)

74
12
11
4

60.0 ±11.9
55.7 ±11.0

85
16

60.3 ±11.6
54.3 ± 10.3

62.2 ±
48.7 ±

1st

2nd

Srd

12
26

9
18

2
8

—
—

11
1
0

9
1

—
—
—

—
—

—

2

4th
1

—
—
—
—

Histologic diagnoses of bone biopsy showed osteoporosis
in 83 patients, osteomalacia in 11, and renal osteodystrophy in 7. Among 83 patients with osteoporosis, 9 (11 %) had
a skeletal imbalance consisting of a dichotomy between
cortical and trabecular histodynamics, 15(18%) had a high
turnover of bone (i.e., increased cellular activity of both
osteoblasts and osteoclasts), and 59 (80%) had a low
turnover of bone (i.e., decreased cellular activity of both
osteoblasts and osteoclasts). Clinical, biochemical, and
radiologic features ofthe last two groups with osteoporosis
were indistinguishable. In four of 11 patients with histologic
osteomalacia, laboratory data were inconclusive so that the
diagnosis was established exclusively by bone biopsy. Two
patients with renal osteodystrophy had features of predominant osteomalacia, four showed features of excess parathyroid hormone effect, and one showed improvement of
osteomalacia as a therapeutic response. One patient in the
entire group showed osteomalacia that was totally unexpected and is still under investigation for proper diagnosis.
Table IV illustrates the complications from the bone biopsy.

TABLEI
Characteristics of Population Studied
Number

No. of patients
in each encounter

Quality ofthe bone specimen was satisfactory in 88 (88%)
cases (Table III). Physician B obtained the highest number
of unsatisfactory specimens, and physician A the least.
Both physician A and C had previously performed more
than 150 transiliac bone biopsies, whereas physician B had
no previous experience. Thus, the quality of specimen
relates to the experience ofthe physician who performs the
procedure. Twelve specimens (12%) were unsatisfactory
(fragmented, one cortex missing, crushed trabeculae, etc),
but were sufficient for diagnostic purposes. The mean
volume of bone specimen was 0.2723 cm^* (0.11300.5770 cm^). Geometric shape, technical artifacts and,
presumably, underlying metabolic process all might have
c o n t r i b u t e d to the w i d e variation in bone specimen
volume.

Fifty patients were evaluated for pain by the pain scoring
method. A further analysis related the pain score to the
number of bone biopsies each patient received (Table 11).
Thirty-eight patients (76%) considered the discomfort as '0'
or ' 1 ' . Twenty-seven had the procedure for the first time and
10 for the second time, eight of whom scored their discomfort as ' 1 ' . We could not assess the previous experience of
these eight patients, since the biopsy had been performed
by a different physician and the pain score had not been
determined. However, they admitted that the second pro-

Race and Sex

No. of
patients

8.7
2.0

cedure was less painful than the previous one. Patients'
knowledge of the procedure or the physician's technical
expertise or both could have contributed to their assessment of less discomfort. This assumption is supported by
the fact that one patient scored '0' even at the fourth
encounter. Eleven patients (22%) scored '2' (nine were first
encounters and two were third encounters). In the latter
two patients, biopsies were performed by the same physician (physician A) on each of the three encounters. They
accepted the procedure because of its value in their management, despite considerable discomfort experienced.
One patient (2%) scored '3', and none scored '4'.

One patient with renal osteodystrophy developed local
hematoma as a result ofthe procedure, probably related to

' V=Lx3.14x(D/2)^ where L is the length ofthe specimen, which in turn
reflects the thickness of the ilium; D is the diameter of the specimen
which cannot exceed 0.7 cm.
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TABLE V

heparin use during subsequent hemodialysis, and it resolved spontaneously. Bone specimens were lost internally
(between the iliacus muscle and inner aspect ofthe ilium)
or externally (external to the bone in subcutaneous tissue
under the fascia lata). Eight specimens lost externally were
retrieved easily by digital exploration without additional
discomfort to the patient. Two specimens lost internally
(one each by physicians A and C) were left in vivo; both
patients were informed but neither developed any longterm complications as a result. In both cases, a second
biopsy was done adjacent to the previously attempted site.
In another case, the cutting end of the trephine separated
from the shaft after pentrating the outer cortex of the ilium
but was removed with a pair of pliers. A successful second
attempt was made without complications. Interestingly, this
patient's pain score was ' 1 ' . None of our patients experienced complications such as femoral nerve palsy (transient
or permanent), skeletal fractures (local or distant), wound
infections, or osteomyelitis. A few patients experienced
local dysesthesia for up to four months, but it resolved
completely with time.

Bone Biopsy Complications

No. of Cases
Hematoma
Neuropathy
Wound infection (Skin)
Pain (7 days)
Fracture
Osteomyelitis
Total No. of
Complications
* Not significantly different.

TABLE III
Quality of Specimen

%
Physician

Total

A

48
42
9

B
C

44

4

8°'o

35
8

7
1

17%
11%

9,030
21
11
6
17
2
1

5,780
14
2
4

58*
(0.64%)

20*
(0.35%)

—
—
—

Complications are either transient or non-existent. Pain is
the single most common complication, but it is reasonably
well accepted, as described above. In a larger survey of
9,030 transiliac bone biopsies compiled from 18 major
centers, the incidence of complications was similar to those
ofthis study (Table V). Furthermore, the incidence did not
significantly differ between the superior (needle trephine)
and lateral (transiliac trephine) approach nor between the
instruments used. Patient acceptability is good, as shown
by the data presented here and as has been reported in a
similar study (7). If necessary precautions are taken (3), the
procedure is no more complicated than any other form of
biopsy. Contrary to the previous report (3), incision of
subcutaneous tissue and fascia lata, rather than blunt dissection, greatly minimizes the discomfort of patients during
or for several days after the procedure. The incised fascia
lata must be sutured with interrupted, absorbable chromic
material to avoid herniation of underlying muscle.

At present, several types of instruments and approaches for
obtaining a bone biopsy are available (3). Transiliac bone
biopsy is probably the method most often used since the

Unsatis- UnsatisFactory Factory

Iliac
Crest

ilium is an easily accessible site. A lateral approach (1)
offers the best opportunity for obtaining a full thickness
(with both inner and outer cortices of ilium) iliac bone
specimen of good quality and of sufficient quantity.

Discussion

SatisFactory

Transiliac
Trephine

Previous
Experience
Yes
No
Yes

TABLE IV
Complications of Transiliac Bone Biopsy
Complications
Total Number
of patients
Hematoma
Instrument problem
Specimens lost*
Femoral nerve palsy
Wound infection
Skeletal fracture
Osteomyelitis
Total
* See text for explanation.

No. of patients
101

100

1

1
1
2

1
2

Diagnostic usefulness of bone biopsy is evident when the
spectrum of histologic findings within the same disease
entity is considered. Although noninvasive techniques
(clinical, biochemical, and radiologic) are often helpful, a
small but significant number of patients will require bone
biopsy either to confirm the diagnosis or guide therapeutic
decision. This is particularly important in patients with
osteoporosis and with renal osteodystrophy, where the
nature of bone disease is not always obvious (8). In another
group of patients with postgastrectomy osteopenia (9),
25% had osteomalacia, despite normal dietary intake of
calcium and calciferol. None of the laboratory data were
helpful in predicting bone histology in this group (9).

%

—
—
—
—

—
—
—

4

4%
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In summary, transiliac bone biopsy can be performed in
outpatients with minimal discomfort. It is reasonably acceptable to patients without sacrificing the quality of bone
needed for diagnostic purposes. Because of its ease and
high diagnostic yield, it should be performed in all patients
w i t h metabolic bone disease unless the diagnosis is
obvious.
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